265 related articles for article (PubMed ID: 19700761)
1. Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis.
Podgorski I; Linebaugh BE; Koblinski JE; Rudy DL; Herroon MK; Olive MB; Sloane BF
Am J Pathol; 2009 Sep; 175(3):1255-69. PubMed ID: 19700761
[TBL] [Abstract][Full Text] [Related]
2. Bone microenvironment modulates expression and activity of cathepsin B in prostate cancer.
Podgorski I; Linebaugh BE; Sameni M; Jedeszko C; Bhagat S; Cher ML; Sloane BF
Neoplasia; 2005 Mar; 7(3):207-23. PubMed ID: 15799821
[TBL] [Abstract][Full Text] [Related]
3. Paracrine factors produced by bone marrow stromal cells induce apoptosis and neuroendocrine differentiation in prostate cancer cells.
Zhang C; Soori M; Miles FL; Sikes RA; Carson DD; Chung LW; Farach-Carson MC
Prostate; 2011 Feb; 71(2):157-67. PubMed ID: 20665531
[TBL] [Abstract][Full Text] [Related]
4. Secreted Protein Acidic and Rich in Cysteine (SPARC) Mediates Metastatic Dormancy of Prostate Cancer in Bone.
Sharma S; Xing F; Liu Y; Wu K; Said N; Pochampally R; Shiozawa Y; Lin HK; Balaji KC; Watabe K
J Biol Chem; 2016 Sep; 291(37):19351-63. PubMed ID: 27422817
[TBL] [Abstract][Full Text] [Related]
5. Loss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.
Sung SY; Liao CH; Wu HP; Hsiao WC; Wu IH; Jinpu ; Yu ; Lin SH; Hsieh CL
PLoS One; 2013; 8(8):e71637. PubMed ID: 23977098
[TBL] [Abstract][Full Text] [Related]
6. Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer.
Hardaway AL; Herroon MK; Rajagurubandara E; Podgorski I
Clin Exp Metastasis; 2015 Apr; 32(4):353-68. PubMed ID: 25802102
[TBL] [Abstract][Full Text] [Related]
7. Augmented osteolysis in SPARC-deficient mice with bone-residing prostate cancer.
McCabe NP; Kerr BA; Madajka M; Vasanji A; Byzova TV
Neoplasia; 2011 Jan; 13(1):31-9. PubMed ID: 21245938
[TBL] [Abstract][Full Text] [Related]
8. Cathepsin K in the bone microenvironment: link between obesity and prostate cancer?
Podgorski I; Linebaugh BE; Sloane BF
Biochem Soc Trans; 2007 Aug; 35(Pt 4):701-3. PubMed ID: 17635127
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow stromal cells enhance prostate cancer cell invasion through type I collagen in an MMP-12 dependent manner.
Nabha SM; dos Santos EB; Yamamoto HA; Belizi A; Dong Z; Meng H; Saliganan A; Sabbota A; Bonfil RD; Cher ML
Int J Cancer; 2008 Jun; 122(11):2482-90. PubMed ID: 18324629
[TBL] [Abstract][Full Text] [Related]
10. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer.
Enriquez C; Cancila V; Ferri R; Sulsenti R; Fischetti I; Milani M; Ostano P; Gregnanin I; Mello-Grand M; Berrino E; Bregni M; Renne G; Tripodo C; Colombo MP; Jachetti E
Cancer Res; 2021 Aug; 81(16):4257-4274. PubMed ID: 34185677
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 in the bone marrow microenvironment promotes the growth and survival of neuroblastoma cells.
Ara T; Song L; Shimada H; Keshelava N; Russell HV; Metelitsa LS; Groshen SG; Seeger RC; DeClerck YA
Cancer Res; 2009 Jan; 69(1):329-37. PubMed ID: 19118018
[TBL] [Abstract][Full Text] [Related]
12. Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone.
Nemeth JA; Harb JF; Barroso U; He Z; Grignon DJ; Cher ML
Cancer Res; 1999 Apr; 59(8):1987-93. PubMed ID: 10213511
[TBL] [Abstract][Full Text] [Related]
13. Targeting cathepsin K diminishes prostate cancer establishment and growth in murine bone.
Liang W; Wang F; Chen Q; Dai J; Escara-Wilke J; Keller ET; Zimmermann J; Hong N; Lu Y; Zhang J
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1999-2012. PubMed ID: 31172267
[TBL] [Abstract][Full Text] [Related]
14. A secreted isoform of ErbB3 promotes osteonectin expression in bone and enhances the invasiveness of prostate cancer cells.
Chen N; Ye XC; Chu K; Navone NM; Sage EH; Yu-Lee LY; Logothetis CJ; Lin SH
Cancer Res; 2007 Jul; 67(14):6544-8. PubMed ID: 17638862
[TBL] [Abstract][Full Text] [Related]
15. Macrophage cathepsin K promotes prostate tumor progression in bone.
Herroon MK; Rajagurubandara E; Rudy DL; Chalasani A; Hardaway AL; Podgorski I
Oncogene; 2013 Mar; 32(12):1580-93. PubMed ID: 22614014
[TBL] [Abstract][Full Text] [Related]
16. Coordinate regulation of microenvironmental stimuli and role of methylation in bone metastasis from breast carcinoma.
Matteucci E; Maroni P; Disanza A; Bendinelli P; Desiderio MA
Biochim Biophys Acta; 2016 Jan; 1863(1):64-76. PubMed ID: 26481505
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer extracellular vesicles mediate intercellular communication with bone marrow cells and promote metastasis in a cholesterol-dependent manner.
Henrich SE; McMahon KM; Plebanek MP; Calvert AE; Feliciano TJ; Parrish S; Tavora F; Mega A; De Souza A; Carneiro BA; Thaxton CS
J Extracell Vesicles; 2020 Dec; 10(2):e12042. PubMed ID: 33408816
[TBL] [Abstract][Full Text] [Related]
18. Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.
Nyambo R; Cross N; Lippitt J; Holen I; Bryden G; Hamdy FC; Eaton CL
J Bone Miner Res; 2004 Oct; 19(10):1712-21. PubMed ID: 15355567
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow adipocytes promote tumor growth in bone via FABP4-dependent mechanisms.
Herroon MK; Rajagurubandara E; Hardaway AL; Powell K; Turchick A; Feldmann D; Podgorski I
Oncotarget; 2013 Nov; 4(11):2108-23. PubMed ID: 24240026
[TBL] [Abstract][Full Text] [Related]
20. Bone-stromal cells up-regulate tumourigenic markers in a tumour-stromal 3D model of prostate cancer.
Windus LC; Glover TT; Avery VM
Mol Cancer; 2013 Sep; 12(1):112. PubMed ID: 24073816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
